Treatment of neuroleptic-induced akathisia with the 5-HT2antagonist mianserin: Double-blind, placebo-controlled study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Serotonin (5-HT): dopamine imbalance may underlie neuroleptic-induced akathisia. Aim: To evaluate the efficacy of the 5-HT 2 antagonist, mianserin in neuroleptic-induced akathisia. Methods: Thirty neuroleptic-treated patients with schizophrenia were randomly allocated in a double-blind design to receive either mianserin (15 mg/day) or placebo for five days. Patients were assessed at baseline and on Days 3 and 5 by the Barnes Akathisia Scale (BARS), as well as by other relevant clinical rating scales. Results: Compared with the placebo group, the mianserin-treated patients showed a significant reduction in all four BARS subscales by Day 5, with mean reductions in the BARS global score of 9.9% and 52.2%, respectively (P=0.006). Response to treatment (a reduction of at least two points on the BARS global subscale), was noted in six patients (40%) in the mianserin group and only one patient (9.1%) in the placebo group (P=0.04, log odds ratio 2.23). Conclusions: Mianserin at a low dose may be a promising therapeutic option for patients with acute neuroleptic-induced akathisia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Halstead, S. M., Barnes, T. R. E., & Speller, J. C. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.177 · Cited by 108
Cited by
Management of common adverse effects of antipsychotic medications
Stroup, T. S., & Gray, N. (2018) · World Psychiatry · doi:10.1002/wps.20567 · Cited by 572
The Assessment and Treatment of Antipsychotic-Induced Akathisia
Pringsheim, T., Gardner, D., Addington, D., Martino, D., Morgante, F., Ricciardi, L., Poole, N., Remington, G., Edwards, M., Carson, A., et al. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718760288 · Cited by 89
Poyurovsky, M., Epshtein, S., Fuchs, C., Schneidman, M., Weizman, R., & Weizman, A. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084027.22282.16 · Cited by 62
Miodownik, C., Lerner, V., Statsenko, N., Dwolatzky, T., Nemets, B., Berzak, E., & Bergman, J. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200603000-00002 · Cited by 47
Lerner, V., Bergman, J., Statsenko, N., & Miodownik, C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1118 · Cited by 44
Avital, A., Gross-Isseroff, R., Stryjer, R., Hermesh, H., Weizman, A., & Shiloh, R. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.006 · Cited by 33
“…mianserin, mirtazapine, trazodone) were also shown to exhibit some beneficial anti-akathisic effect and are currently conceptualized as second-line treatments for akathisia (Poyurovsky et al., 1999; Miller et al., 1990; Poyurovsky et al., 2006; Weiss et al., 1995; Fischel et al., 2001).”
BackgroundSelf-citationGerolymos, C., Barazer, R., Yon, D. K., Loundou, A., Boyer, L., & Fond, G. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.1527 · Cited by 28
Metadata
- Authors
- Poyurovsky, M., Shardorodsky, M., Fuchs, C., Schneidman, M., & Weizman, A.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1999-03
- Volume
- 174
- Issue
- 3
- Pages
- 238-242
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2036658484
- Cited by
- 73
- References
- 1
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.